RA Capital Nexus Fund, L.P.

Track

Insider profile

RA Capital Nexus Fund, L.P.'s trades of Sionna Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-21 2025-11-21
PrS Proposed sale
56,109
498.71
US$3,515,434 		56,109 498.71 US$3,515,434
2025-11-20 2025-11-20
PrS Proposed sale
68,620
421.89
US$2,015,472 		68,620 421.89 US$2,015,472
2025-11-19 2025-11-19
PrS Proposed sale
41,047
374.42
US$2,283,176 		41,047 374.42 US$2,283,176
2025-11-18 2025-11-18
PrS Proposed sale
2,728
39.04
US$106,501 		2,728 39.04 US$106,501
2025-11-17 2025-11-17
PrS Proposed sale
32,310
39.93
US$1,290,138 		32,310 39.93 US$1,290,138
2025-10-28 2025-10-28
PrS Proposed sale
31,392
39.45
US$1,238,414 		31,392 39.45 US$1,238,414
2025-10-24 2025-10-24
PrS Proposed sale
122,271
39.21
US$4,794,246 		122,271 39.21 US$4,794,246
2025-10-20 2025-10-20
PrS Proposed sale
15,104
29.43
US$444,511 		15,104 29.43 US$444,511
2025-10-17 2025-10-17
PrS Proposed sale
42,816
29.00
US$1,241,664 		42,816 29.00 US$1,241,664
2025-10-16 2025-10-16
PrS Proposed sale
24,916
29.06
US$724,059 		24,916 29.06 US$724,059
2025-10-15 2025-10-15
PrS Proposed sale
8,430
30.22
US$254,755 		8,430 30.22 US$254,755
2023-12-18 2023-12-18
PrS Proposed sale
295,650
0.94
US$279,034 		295,650 0.94 US$279,034
2023-12-12 2023-12-12
PrS Proposed sale
36,959
0.90
US$33,263 		36,959 0.90 US$33,263
2023-11-27 2023-11-27
PrS Proposed sale
151,778
1.29
US$195,793 		151,778 1.29 US$195,793
2023-11-21 2023-11-21
PrS Proposed sale
78,983
2.06
US$162,704 		78,983 2.06 US$162,704